These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11137651)

  • 21. Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.
    Milne KE; Gould IM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4071-7. PubMed ID: 22585220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosis.
    Van Dalfsen JM; Stapp JR; Phelps C; Stewart P; Burns JL
    J Clin Microbiol; 2002 Jan; 40(1):26-30. PubMed ID: 11773088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosolized tobramycin in patients with cystic fibrosis.
    Ashby BL; Stern DH
    N Engl J Med; 1993 Nov; 329(22):1659-60. PubMed ID: 8232450
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.
    Graff GR; Burns JL
    Chest; 2002 Jun; 121(6):1754-60. PubMed ID: 12065335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
    Anderson SW; Stapp JR; Burns JL; Qin X
    J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
    MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
    J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
    King P; Lomovskaya O; Griffith DC; Burns JL; Dudley MN
    Antimicrob Agents Chemother; 2010 Jan; 54(1):143-8. PubMed ID: 19805554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.
    San Gabriel P; Zhou J; Tabibi S; Chen Y; Trauzzi M; Saiman L
    Antimicrob Agents Chemother; 2004 Jan; 48(1):168-71. PubMed ID: 14693535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S;
    Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
    Wiesemann HG; Steinkamp G; Ratjen F; Bauernfeind A; Przyklenk B; Döring G; von der Hardt H
    Pediatr Pulmonol; 1998 Feb; 25(2):88-92. PubMed ID: 9516091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.
    Hagerman JK; Knechtel SA; Klepser ME
    Expert Opin Pharmacother; 2007 Mar; 8(4):467-75. PubMed ID: 17309341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
    Colin AA; Ali-Dinar T
    Pediatr Pulmonol; 2010 Jun; 45(6):626-7. PubMed ID: 20503290
    [No Abstract]   [Full Text] [Related]  

  • 36. Microbiology of sputum from patients at cystic fibrosis centers in the United States.
    Burns JL; Emerson J; Stapp JR; Yim DL; Krzewinski J; Louden L; Ramsey BW; Clausen CR
    Clin Infect Dis; 1998 Jul; 27(1):158-63. PubMed ID: 9675470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Barclay ML; Begg EJ; Chambers ST; Thornley PE; Pattemore PK; Grimwood K
    J Antimicrob Chemother; 1996 Jun; 37(6):1155-64. PubMed ID: 8836818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.
    Geller DE; Pitlick WH; Nardella PA; Tracewell WG; Ramsey BW
    Chest; 2002 Jul; 122(1):219-26. PubMed ID: 12114362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
    Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.